Healthcare company Healius (ASX:HLS) changed the terms of employment of Chief Executive Officer Paul Anderson, according to a Monday filing with the Australian bourse.
The CEO's tenure will now move to "permanent ongoing employment, subject to termination," from a fixed term ending June 30, 2026.
Anderson's fixed annual remuneration will also be increased to AU$1.3 million from AU$1.1 million, effective Jan. 1.
Further, the CEO's fiscal year 2027 bonus arrangements will include short- and long-term incentives to align with the remuneration structure for other key management personnel, pending performance measures, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。